The FDA will put three psychedelic drug programs on an ultra-fast approval track, compressing review timelines from roughly ...

President Trump signed an executive order Saturday for a speedy review of psychedelic drugs, including ibogaine.

In a 2017 study, researchers administered a 12 mg/kg dose of ibogaine to 30 participants with opioid dependence and tracked ...

President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health ...

A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental ...

President Trump signed an executive order on Saturday to make some psychedelic drugs more available to treat mental health ...

Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to ...

The president issued an executive order increasing research into drugs used to treat PTSD and other disorders.